OBJECTIVE: Insulin-responsive adipogenic signaling molecules include insulin receptor substrates (IRS)-1 and -2, phosphoinositide 3-kinase (PI3K), and protein kinase B (PKB; also known as Akt). Mammalian target of rapamycin (mTOR) is a PKB substrate, and regulates p70 S6 kinase (p70 S6K). Since p70 S6K is an insulin-responsive kinase downstream of PI3K and PKB, its potential role in adipogenic insulin signaling was investigated. DESIGN: We measured the effect of rapamycin, a specific inhibitor of mTOR, on insulin-induced 3T3-L1 adipogenesis and on insulin-stimulated p70 S6K activation. RESULTS: Rapamycin partially reduced differentiation, measured by Oil Red O staining, triacylglycerol accumulation (by up to 46%), and peroxisome proliferator-activated receptor g protein expression (by 50%). In contrast, rapamycin completely inhibited insulin-stimulated p70 S6K activation, assessed by phosphorylation of p70 S6K and its substrate, S6. Expression of a constitutively activated form of p70 S6K did not promote 3T3-L1 adipogenesis. The considerable residual differentiation in the presence of rapamycin, despite the complete blockade of p70 S6K activation, prompted us to measure the phosphorylation of another rapamycin-sensitive protein, eukaryotic initiation factor 4E (eIF4E) binding protein 1 (4E-BP1). Insulin-stimulated 4E-BP1 phosphorylation in 3T3-L1 preadipocytes was only partially affected by rapamycin, consistent with the differentiation data. Phosphorylation of eIF4E itself, an expected consequence of 4E-BP1 phosphorylation, was also only partially inhibited. CONCLUSION: Our data suggest that adipogenic mTOR signaling occurs via the 4E-BP1/eIF4E pathway, rather than through p70 S6K.
Introduction
Adipose tissue expands as existing adipocytes enlarge and as new adipocytes mature from fibroblast-like preadipocytes. 1 The murine 3T3-L1 cell line is an established insulinresponsive preadipocyte model for the study of adipogenesis. 2, 3 Adipogenic insulin signaling in preadipocytes depends on several signaling molecules, including insulin receptor substrate (IRS)-1 and -2, phosphoinositide 3-kinase (PI3K), and protein kinase B (PKB; also known as Akt). [4] [5] [6] [7] activation is sufficient to trigger differentiation of confluent 3T3-L1 preadipocytes, but the molecular pathway downstream of PKB is not clearly understood. 6, 7 The insulin-sensitive serine/threonine kinase, p70 S6 kinase (p70 S6K), is positioned downstream of PKB, although not a direct PKB substrate. 8 Phosphorylation of the S6 subunit of the 40S ribosome by p70 S6K is correlated with mitogenic stimulation and increased translation of mRNAs with a 5 0 -terminal oligopyrimidine tract (5 0 -TOP). p70 S6K also phosphorylates cAMP response element binding protein (CREB), a transcription factor that promotes adipogenesis. 9, 10 PKB may phosphorylate mammalian target of rapamycin (mTOR), and mTOR regulates p70 S6K activity. 11, 12 mTOR is selectively inhibited by rapamycin. 13 Rapamycin has been reported to inhibit the differentiation of preadipocyte into adipocytes. [14] [15] [16] Eukaryotic initiation factor 4E binding protein 1 (4E-BP1; also known as PHAS-I) is another protein whose phosphorylation depends on mTOR. 13 When unphosphorylated, it binds to and inactivates eukaryotic initiation factor 4E (eIF4E). Phosphorylated 4E-BP1 releases eIF4E, allowing it to be phosphorylated and to activate cap-dependent translation of mRNA with highly structured 5 0 untranslated regions.
17 4E-BP1-deficient mice develop less fat, suggesting an adipogenic role for this protein. 18 In this study, we have examined the effect of rapamycin on insulin-induced 3T3-L1 preadipocyte differentiation compared to insulin-stimulated p70 S6K activity. The effect of an activated p70 S6K construct on adipogenesis was analyzed. Parallel studies compared the effect of rapamycin on 4E-BP1 phosphorylation.
Experimental
3T3-L1 preadipocyte culture and acute insulin stimulation 3T3-L1 preadipocytes obtained from American Type Culture Collection (Rockville, MD, USA) were maintained at low passage. Preadipocytes were grown to confluence in Dulbecco's modified Eagle's medium (DMEM), supplemented with 10% calf serum (CS), penicillin (100 U/ml), and streptomycin (0.1 mg/ml) (all from Life Technologies). Confluent 3T3-L1 preadipocytes, washed with Krebs-Ringer HEPES buffer, were stimulated with insulin (10 or 100 nM) for up to 60 min. When indicated, cells were pretreated for 15 min with 10 or 100 nM rapamycin, 50 mM LY294002 (Sigma), 100 nM wortmannin (Kamiya BioMed), or vehicle (0.1% DMSO).
Assessment of preadipocyte differentiation
At 2 days postconfluence, 3T3-L1 preadipocytes were induced to differentiate over 8 days with 100 nM insulin; 0.25 mM dexamethasone and 0.5 mM isobutylmethylxanthine were present for the first 2 days. When indicated, rapamycin (10 or 100 nM, Calbiochem) or vehicle (0.1% DMSO) was added to the differentiation medium, and replaced daily. Cellular triacylglycerol (TG) was measured as described. 19, 20 Protein concentrations were assayed using a modified Lowry method with bovine serum albumin as a standard (Sigma). Alternatively, cells were fixed in 10% formalin, stained with a 0.3% Oil Red O (Sigma) in 60% isopropanol solution, 15 and then photographed with a Nikon Coolpix 995 camera mounted on a Nikon Eclipse TS100 microscope.
Constructs and retroviral infections
An activated myc-tagged p70 S6K-D 3 E cDNA construct, a gift from Dr George Thomas (Friedrich Miescher Institut, Basel, Swizerland), 21 was subcloned into the EcoR1/XhoI site of the pLXSN retroviral vector. The GP þ E packaging cells (provided by Dr Douglas Gray, University of Ottawa) were cultured in DMEM supplemented with 10% fetal bovine serum, 100 U/ml penicillin, and 0.1 mg/ml streptomycin. Upon reaching 80% confluence, cells were transiently transfected with pLXSN or pLXSN-D 3 E p70 S6K by the calcium phosphate method. Viral supernatants were collected 48 h post-transfection, filtered, and added along with 4 mg/ml of polybrene to proliferating 3T3-L1 preadipocytes for 24 h. 22 After reaching confluence, cells were induced to undergo differentiation as described. Under these conditions, over 90% of preadipocytes expressed the retroviral vector. The level of p70 S6K activity in the transfected cell cultures was measured using an in vitro p70 S6K assay kit (Upstate Biotechnology).
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Immunoblot analysis Cells were lysed in Laemmli buffer, 24 supplemented with 1 mM Na 3 VO 4 for peroxisome proliferator-activated receptor g (PPARg) immunoblots, and with 5 mM EGTA, 5 mM NaPPi, 50 mM NaF, and 1 mM microcystin for all other analyses. Lysate protein was quantified using a modified Lowry assay (Sigma) and equal quantities of protein (15-50 mg for all immunoblots, except 120 mg for phospho-eIF4E/eIF4E analysis) were resolved by SDS-PAGE, followed by electrophoretic transfer onto a nitrocellulose membrane (Bio-Rad).
The membrane was probed with the following primary antibodies: polyclonal rabbit anti-p70 S6K (0.4 mg/ml), monoclonal mouse anti-PPARg (2 mg/ml), polyclonal rabbit anti-4E-BP1 (1 mg/ml; all from Santa Cruz), polyclonal rabbit anti-phospho-S6 protein (1:5000; gift from Dr Morris Birnbaum, University of Pennsylvania), monoclonal mouse anti-fatty acid synthase (FAS) (1 mg/ml; BD Biosciences), polyclonal rabbit anti-phospho-Ser209 eIF4E (1:250), polyclonal rabbit anti-eIF4E (1:1000), polyclonal rabbit antiphospho-Ser807/911 Rb (1:500), or polyclonal rabbit anti-Rb (1:1000; all from Cell Signaling). The blots were incubated in the appropriate peroxidase-conjugated secondary antibody, and immunoreactivity was visualized by enhanced chemiluminescence (Amersham). Immunoblot exposures were scanned using the Gel Doc 1000 system (Bio-Rad Laboratories), and bands were quantified by volume analysis using Molecular Analyst version 1.4 software (Bio-Rad Laboratories).
Statistical analysis
Differences between means were assessed by ANOVA and Tukey's post-test, using GraphPad InStat version 3.00 for Windows 98 (GraphPad Software, San Diego, CA, USA), with P-valueso0.05 considered significant.
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Results p70 S6K and 4E-BP1 expression during adipogenesis Confluent 3T3-L1 preadipocytes were differentiated as described, and p70 S6K and 4E-BP1 protein expression was monitored by immunoblot analysis (Figure 1a ). Whereas the amount of p70 S6K remained stable, there was a three-fold increase in the level of 4E-BP1 during adipogenesis. The five-fold increase in the amount of the adipogenic transcription factor PPARg (PPARg1 and PPARg2, alternatively spliced isoforms) confirmed successful adipose differentiation.
Rapamycin partially inhibits adipogenesis
We studied the effect of rapamycin on insulin-induced differentiation of 3T3-L1 preadipocytes cultured in CS (Figure 1b-d) . Under these conditions, no differentiation was detected when preadipocytes were maintained in CS alone, and rapamycin had no effect on preadipocytes maintained in the control medium. Oil Red O staining indicated that B80% of the cells underwent adipose conversion, consistent with the increases in TG accumulation and PPARg induction that were observed. Rapamycin reduced the amount of Oil Red O staining, Figure 1 Adipogenesis and the effect of rapamycin. (a) Confluent 3T3-L1 preadipocytes were induced to differentiate as described. Cells were lysed on the indicated days, and equal amounts of solubilized protein were separated by SDS-PAGE, transferred to nitrocellulose, and immunoblotted with antibodies against p70 S6K, 4E-BP1, or PPARg. Immunoblots from one experiment are shown, along with densitometric data (means7s.e.m.) from three independent experiments. In the subsequent panels, confluent 3T3-L1 preadipocytes were either maintained in control media or induced to differentiate for 8 days, in the presence of 10 or 100 nM rapamycin, or vehicle control, as described. 
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and at 10 and 100 nM, it decreased TG levels by 23% (Po0.05) and 46%, respectively (Po0.01). Rapamycin, at either dose, also diminished the level of PPARg protein expression by 50%.
Phosphorylation of p70 S6K and 4E-BP1 in insulin-stimulated 3T3-L1 preadipocytes We examined the time course for phosphorylation of p70 S6K and 4E-BP1 in response to insulin. Preadipocytes stimulated with insulin underwent a marked increase in p70 S6K phosphorylation by 15 min, as indicated by the characteristic upward mobility shift on immunoblot analysis (Figure 2a) . Phosphorylation of p70 S6K was transient, with a return to its basal level by 30 min. This agrees with our previous data using an in vitro kinase assay. 16 Optimal phosphorylation of 4E-BP1 (upward mobility shift) occurred by 15 min, and, unlike p70 S6K, was sustained up to 60 min (Figure 2b ). Therefore, for subsequent studies evaluating p70 S6K and 4E-BP1 phosphorylation in parallel, a 15 min period of stimulation was used.
Effect of rapamycin on phosphorylation of p70 S6K and 4E-BP1 in insulin-stimulated 3T3-L1 preadipocytes In response to insulin stimulation (10 or 100 nM), phosphorylation of p70 S6K was completely abrogated by rapamycin (10 or 100 nM) (Figure 2c and e). The absence of S6 phosphorylation by p70 S6K, a cellular substrate of p70 S6K, further demonstrated the total blockade by rapamycin. Given that the antiadipogenic effect of rapamycin at these concentrations was only partial (Figure 1 ), the data argue against a major role for p70 S6K in the preadipocyte differentiation response. In contrast, rapamycin did not fully prevent the insulinstimulated 4E-BP1 upper band shift indicative of phosphorylation. Only a limited inhibition of 4E-BP1 phosphorylation occurred with either dose of insulin in combination with 4E-BP1 and p70 S6K in adipogenesis D El-Chaâr et al either dose of rapamycin (Figure 2d and f) . We directly measured insulin-stimulated eIF4E phosphorylation and found that, as for 4E-BP1, the inhibitory effect of rapamycin was incomplete.
An activated p70 S6K construct does not affect adipocyte differentiation
To explore the relevance of p70 S6K for adipogenesis, we used retroviral infection to generate 3T3-L1 preadipocytes expressing activated p70 S6K mutant, p70 S6K-D 3 E (Figure 3 ). p70 S6K activity in preadipocyte overexpressors, measured by in vitro p70 S6 kinase assay, was 9.871.6-fold higher than that in empty-vector preadipocytes (n ¼ 2 independent infections). Differentiation of confluent preadipocytes was assessed by morphological appearance and immunoblot analysis of PPARg. Despite expression of the constitutively activated p70 S6K-D 3 E, there was no evidence of accelerated or enhanced differentiation, compared to preadipocytes that were either infected with empty vector or left uninfected.
Effect of LY294002 and wortmannin on 4E-BP1 phosphorylation in insulin-stimulated 3T3-L1 preadipocytes PKB, activated through PI3K, may activate a pathway leading to 4E-BP1 phosphorylation that is distinct from mTOR. 25 We treated 3T3-L1 preadipocytes with two structurally unrelated PI3K inhibitors, LY294002 or wortmannin, to determine their effect on 4E-BP1 phosphorylation (Figure 4 ). Both LY294002 and wortmannin completely inhibited insulinstimulated 4E-BP1 phosphorylation, without added rapamycin, suggesting that PI3K-dependent signals are essential for 4E-BP1 phosphorylation.
Effect of rapamycin on Rb phosphorylation during adipogenesis Both p70 S6K and 4E-BP1 are indirect regulators of Rb phosphorylation. Phosphorylation of Rb modulates the cell cycle and therefore the early clonal expansion that is important for 3T3-L1 adipogenesis. 26, 27 We examined the effect of rapamycin on Rb phosphorylation during adipogenesis ( Figure 5 ). Rb phosphorylation occurred at day 1 of the differentiation protocol, as expected. 26, 27 Despite the 4E-BP1 and p70 S6K in adipogenesis D El-Chaâr et al absolute inhibition of p70 S6K caused by rapamycin in insulin-stimulated preadipocytes, there was only a modest 32% inhibition (Po0.05) of Rb phosphorylation. This partial inhibition is in line with what was observed for insulinstimulated 4E-BP1 phosphorylation, and suggests that 4E-BP1, rather than p70 S6K, is a more important regulator of Rb phosphorylation.
Discussion
Our data show that although p70 S6K and 4E-BP1 are regulated by mTOR, they differ in their sensitivity to the inhibitory actions of rapamycin. The partial inhibition of insulin-induced 4E-BP1 phosphorylation, compared to the complete absence of p70 S6K phosphorylation, is consistent with the effect of rapamycin on insulin-induced adipogenesis and Rb phosphorylation. Expression of an activated mutant p70 S6K did not promote adipogenesis, further suggesting that p70 S6K does not play a major role in insulininduced adipogenesis. Previous work has implicated the insulin receptors, IRS-1 and -2, PI3K, and PKB in insulin-induced adipogenesis. [4] [5] [6] [7] A role for p70 S6K in adipogenesis could be hypothesized, based on the rationale that it is an insulinresponsive kinase, is positioned downstream of PKB, and phosphoylates CREB, an adipogenic transcription factor. [8] [9] [10] PKB may serve as a relay in the activation of p70 S6K via its phosphorylation of mTOR, an established regulator of p70 S6K. 11, 12 Rapamycin has been reported to inhibit adipogenesis. [14] [15] [16] 28 However, we found that concentrations of rapamycin that unequivocally blocked insulin-stimulated p70 S6K phosphorylation only inhibited adipogenesis to a limited degree. This discordance suggests that the absence of p70 S6K activity does not have a major impact on preadipocyte differentiation. This novel observation is consistent with, and may provide a mechanistic basis for, the unaffected adipose tissue phenotype described for the p70 S6K-null mouse. 29 In contrast, inhibition of insulinstimulated 4E-BP1 phosphorylation by rapamycin was incomplete, in line with the partial inhibition of adipogenesis. Interestingly, 4E-BP1-null mice have a reduced adipose tissue mass. 18 Rapamycin did not equally inhibit the insulin-stimulated phosphorylation of p70 S6K (and S6 phosphorylation) compared to that of 4E-BP1 (and eIF4E phosphorylation), even though both proteins are regulated by mTOR. p70 S6K activation is mediated by several protein kinases resulting in phosphorylation at several residues, some of which are susceptible to inhibition by rapamycin. 30 The complete inhibition of insulin-stimulated p70 S6K and S6 phosphorylation by rapamycin in 3T3-L1 preadipocytes demonstrates that mTOR-dependent events are crucial for activation of p70 S6K.
Since the inhibition of insulin-stimulated 4E-BP1 phosphorylation by rapamycin was incomplete, it appears that other insulin-stimulated kinases can phosphorylate 4E-BP1. MAPK was implicated as a 4E-BP1 kinase, but subsequent studies did not confirm this. 31, 32 We found that inhibition of PI3K completely blocked insulin-stimulated 4E-BP1 phosphorylation. The PI3K/PKB pathway might be responsible for the persistent phosphorylation of 4E-BP1 that occurs in the presence of rapamycin. Activated PKB mutants have been shown to induce 4E-BP1 phosphorylation, indicating that PKB is sufficient for 4E-BP1 phosphorylation, although not acting on it directly. 33 The PKB-regulated kinase that phosphorylates 4E-BP1 in vivo has not yet been identified. Rb phosphorylation is an important event for adipogenesis. [26] [27] [28] Upon differentiation, the phosphorylation of Rb by cyclin D (1 or 3)/cyclin-dependent kinase (cdk-4 or-6) by day 1 releases E2F, permitting the start of the clonal expansion phase of adipogenesis. 28, 34 The phosphorylation of 4E-BP1 allows eIF4E to increase the translation of cyclin D1, and p70 S6K is linked to Rb phosphorylation through upregulation of cyclin D3; both will promote Rb phosphorylation via the cyclin D/cdk complex. 35 Rb phosphorylation peaks at day 1 of insulin-induced 3T3-L1 differentiation, 28, 34 and the partial inhibition we observed with rapamycin is consistent with that of 4E-BP1 phosphor- 4E-BP1 and p70 S6K in adipogenesis D El-Chaâr et al ylation. Further study is required in order to establish 4E-BP1 as the key regulator of Rb phosphorylation during adipogenesis.
Regulation of preadipocyte differentiation, in particular through the insulin signalling pathway, appears to play a critical role in the formation and maintenance of adipocytes. mTOR, with its nutrient-sensing functions, may turn out to be a key signalling molecule involved in energy storage. Recently, mTOR has been reported to mediate the insulinstimulated phosphorylation of lipin, a protein that appears to be essential for normal adipose tissue development. 36 Further elucidation of mTOR-regulated pathways should increase our understanding of adipogenesis.
